Time-Dependent COVID-19 Mortality in Patients With Cancer
OnCovid study group(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Ariadna Roqué(Institut Català d'Oncologia), M. Carmen Carmona-García(München Klinik), Anna Pous(Institut Català d'Oncologia), Lorenza Scotti(University of Milano-Bicocca), Joanne Evans, Eudald Felip(University of Ioannina), Daniele Generali(University of Trieste), Salvatore Grisanti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Diego Ottaviani(Royal London Hospital), John Chester(Velindre Cancer Centre), N. Saoudi Gonzalez, Nadia Harbeck(Breast Center), Alessandro Parisi(Marche Polytechnic University), Alberto Zambelli, Alexia Bertuzzi(Humanitas University), Ramón Salazar(Institut Català d'Oncologia), Vittoria Fotia(Ospedale Papa Giovanni XXIII), Ailsa Sita-Lumsden(Guy's and St Thomas' NHS Foundation Trust), María Laura Fox(Vall d'Hebron Hospital Universitari), Sabrina Rossi(IRCCS Humanitas Research Hospital), Rossella Bertulli(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlo Tondini(Ospedale Papa Giovanni XXIII), Saoirse Dolly(Guy's and St Thomas' NHS Foundation Trust), Uma Mukherjee(University College London Hospitals NHS Foundation Trust), Joan Brunet(Institut Català d'Ornitologia), Johann Colomba(Guy's and St Thomas' NHS Foundation Trust), Meera Patel(Wayne State University), Mark Bower(Chelsea and Westminster Hospital), Émeline Colomba(Université Paris-Saclay), Paolo Pedrazzoli(Policlinico San Matteo Fondazione), Krishnie Srikandarajah(Guy's and St Thomas' NHS Foundation Trust), Paola Queirolo, Federica Biello(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Marco Tagliamento(Ospedale Policlinico San Martino), Bruno Vincenzi(Campus Bio Medico University Hospital), Alessia Dalla Pria(Hammersmith Hospital), Fanny Pommeret(Université Paris-Saclay), Matteo Lambertini(Ospedale Policlinico San Martino), Angela Loizidou(Université Libre de Bruxelles), Beth Russell(King's College London), Alice Baggi(Vall d'Hebron Hospital Universitari), Gianpiero Rizzo(Policlinico San Matteo Fondazione), Michela Libertini(Fondazione Poliambulanza Istituto Ospedaliero), Giampero Porzio(University of L'Aquila), Claudia Andrea Cruz(Ospedale Papa Giovanni XXIII), Charlotte Moss(King's College London), Raquel Liñan(Institut Català d'Oncologia), Elia Seguí, David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 72
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k